GSK Fails Again To Nix Antitrust Claims Over Wellbutrin

Law360, New York (September 1, 2010, 6:48 PM EDT) -- A federal judge has foiled GlaxoSmithKline PLC's latest campaign to dismiss direct purchaser claims in a class action accusing the drugmaker of filing baseless patent suits to delay generic competition in the market for antidepressant Wellbutrin SR.

Judge Lawrence F. Stengel of the U.S. District Court for the Eastern District of Pennsylvania on Tuesday denied GSK's renewed motion for summary judgment and its motion to reconsider his previous summary judgment order, ruling that the court had not erred in allowing claims from the direct purchasers and...
To view the full article, register now.